Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Indications for the Treatment of Myocardial Infarction with Corticosteroids

  • Chapter
Critical Care Medicine Manual

  • 84 Accesses

Abstract

For over 20 years, only sporadic attention has been given to the use of corticosteroids in the treatment of acute myocardial infarction and its various complications. There is now considerable interest as to whether this agent or any other type of therapeutic intervention can limit the size of an acute myocardial infarction. Laboratory experimentation indicates that this may apply, to humans as well as animals, and if so, it would be reasonable to assume that the use of corticosteroids will become far more widespread.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Braunwald, E., Maroko, P. R., and Libby, P. (1974). Reduction of infarct size following coronary occlusion. Circ. Res. 34/35:III–192.

    Google Scholar 

  2. Chapman, D. W., Skaggs, R. H., Thomas, J. R., and Greene, J. A. (1952). The effect of cortisone in experimental myocardial infarction. Am. J. Med. Sci. 223:41.

    Article  PubMed  CAS  Google Scholar 

  3. Crampton, R. S., Wangensteen, S. L., and Lovett, W. L. (1972). Production of myocardial depressant in shock following acute myocardial depressant in shock following acute myocardial infarction: Preliminary evaluation of treatment with methylprednisolone. Am. J. Cardiol. 29:257.

    Article  Google Scholar 

  4. Dall, J. L. C., and Peel, A. A. F. (1963). A trial of hydrocortisone in acute myocardial infarction. Lancet 2:1098.

    Google Scholar 

  5. Dietzman, R. H., and Lillehei, R. C. (1968). The treatment of cardiogenic shock. V. The use of corticosteroids in the treatment of cardiogenic shock. Am. Heart J. 75:214.

    Google Scholar 

  6. DonMichael, T. A., Forrester, J. S., Allen, H. N., and Swan, H. J. C. (1972). Identification of clinical subset in cardiogenic shock. Am. J. Cardiol. 29:280.

    Article  Google Scholar 

  7. Ebdid, M., Caramell, Z., Netos, S. M., Dossantos, M. I. R., Tranchesi, J., Barbato, E., Pilleggi, F., and Decourt, L. V. (1965). The effects of large intravenous dose of hydrocortisone or hyaluronidase on the electrocardiographic pattern of acute myocardial infarction. Arch. Inst. Cardiol. Mex. 35:3.

    Google Scholar 

  8. Jewitt, D. E., Skelton, C. L., and Sonnenblick, E. H. (1972). Salutary effect of methylprednisolone (MP) on the viability of heart muscle exposed to anoxia (abstr.). Circulation 45/46:11–121.

    Google Scholar 

  9. Johnson, A. S., Scheinberger, S. R., Gerish, R. A., and Saltzstein, H. C. (1953). The effect of cortisone on the size of experimentally produced myocardial infarcts. Circulation 7:224.

    PubMed  CAS  Google Scholar 

  10. Lefer, A. M., and Martin, J. (1969). Mechanism of the protective effect of corticosteroids in hemorrhagic shock. Am. J. Physiol. 216:314.

    PubMed  CAS  Google Scholar 

  11. Libby, P., Maroko, P. R., and Bloor, C. M. (1973). Reduction of experimental myocardial infarct size by corticosteroid administration. J. Clin. Invest. 52:599.

    Article  PubMed  CAS  Google Scholar 

  12. Maley, T., Gulotta, S., and Morrison, T. (1974). Effect of methylprednisolone on predicted myocardial infarct size in man. Clin. Res. 22:288A.

    Google Scholar 

  13. Maroko, P. R., Kjekshus, J. K., Sobel, B. E., Watanabe, T., Covell, J. W., and Ross, J., Jr. (1971). Factors in influencing infarct size following experimental coronary artery occlusions. Circulation 43:61.

    Google Scholar 

  14. Masters, T. M., Harbold, N. B., and Hall, D. G. (1974). Beneficial effects of methylprednisolone sodium succinate (MPSS) with acute myocardial infarction. Circulation 50:111–119.

    Google Scholar 

  15. Opdyke, D. A., Lambert, A., Stoerk, H. C., Zanetti, M. E., and Kuna, S. (1953). Failure to reduce the size of experimentally produced myocardial infarcts by cortisone treatment. Circulation 5:544.

    Google Scholar 

  16. Peel, A. A. F. (1962). Steroid therapy in acute myocardial infarct. Proceedings of World Congress of Cardiology, Mexico City.

    Google Scholar 

  17. Prinzmetal, M., and Kennamer, R. (1954). Emergency treatment of cardiac arrhythmias. J. Am. Med. Assoc. 154:13.

    Article  Google Scholar 

  18. Semphe, T., and Dall, J. L. C. (1965). Steroids in myocardial infarction. Am. Heart J. 70:116.

    Google Scholar 

  19. Sieves, J., Johansen, T., and Prednine, L. N. (1962). Treatment of myocardial infarction. Proceeding of World Congress of Cardiology, Mexico City.

    Google Scholar 

  20. Steroids and Shock. Baltimore: Thomas M. Glenn, University Park Press, 1974.

    Google Scholar 

  21. Swan, H. J. C. (1972). Power failure of the heart in acute myocardial infarction. In: Likoff, W., Segal, B. L., Insull, W., and Moyer, J. H. (eds.), Atherosclerosis and Coronary Heart Disease, New York: Grune and Stratton, pp. 453–467.

    Google Scholar 

  22. Vyden, J. K., Nagasawa, K., Rabinowitz, B., Parmley, W. W., Tomoda, H., Corday, E., and Swan, H. J. C. (1974). Effects of methylprednisolone administration in acute myocardial infarction. Am. J. Cardiol. 34:611.

    Google Scholar 

  23. Weil, M. H., and Whigham, H. (1965). Corticosteroids for reversal of hemorrhagic shock in rats. Am. J. Physiol. 209:815.

    PubMed  CAS  Google Scholar 

  24. Wilson, J. W. (1972). Treatment or prevention of pulmonary cellular damage with pharmacologic doses of corticosteroids. Surg. Gynec. Obstet. 134:615.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vascular Diagnostic Laboratory, Cedars-Sinai Medical Center, USA

    John K. Vyden M.D. (Medical Director, Associate Professor of Medicine)

  2. University of California at Los Angeles School of Medicine, Los Angeles, California, USA

    John K. Vyden M.D. (Medical Director, Associate Professor of Medicine)

  3. Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA

    Teruo Takano M.D. (Research Fellow)

Authors
  1. John K. Vyden M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teruo Takano M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Vyden, J.K., Takano, T. (1978). Indications for the Treatment of Myocardial Infarction with Corticosteroids. In: Critical Care Medicine Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-9932-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-9932-5_21

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-9934-9

  • Online ISBN: 978-1-4612-9932-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation